| Dr Jennifer Lynn Brenton, MD | |
|
19 Friendship St Unit 220, Newport, RI 02840-2264 | |
| (401) 848-5556 | |
| Not Available |
| Full Name | Dr Jennifer Lynn Brenton |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 19 Friendship St Unit 220, Newport, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649364498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD14808 (Rhode Island) | Primary |
| Entity Name | Swedish Covenant Management Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760432348 PECOS PAC ID: 4486556016 Enrollment ID: O20040123000850 |
News Archive
Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled "How Can I Build a Microscopy System for Optogenetics?" led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Covidien, a manufacturer of medical devices, pharmaceuticals and medical supplies, based in Mansfield, Mass., has pledged $375,000 and is a "Visionary" level supporter.
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
Selenium may offer an intervention strategy for the treatment of prostate cancer according to results of a study from the laboratory of Allen Gao, PhD, which will be presented by Yan Hu, PhD, Departments of Medicine and Pharmacology and Therapeutics, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.
Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients - This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.
› Verified 1 days ago
| Entity Name | Obhg Illinois Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700107216 PECOS PAC ID: 7810179702 Enrollment ID: O20110314001065 |
News Archive
Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled "How Can I Build a Microscopy System for Optogenetics?" led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Covidien, a manufacturer of medical devices, pharmaceuticals and medical supplies, based in Mansfield, Mass., has pledged $375,000 and is a "Visionary" level supporter.
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
Selenium may offer an intervention strategy for the treatment of prostate cancer according to results of a study from the laboratory of Allen Gao, PhD, which will be presented by Yan Hu, PhD, Departments of Medicine and Pharmacology and Therapeutics, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.
Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients - This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Lynn Brenton, MD 117 Ellenfield St Ste 101, Providence, RI 02905-4541 Ph: (401) 444-6779 | Dr Jennifer Lynn Brenton, MD 19 Friendship St Unit 220, Newport, RI 02840-2264 Ph: (401) 848-5556 |
News Archive
Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled "How Can I Build a Microscopy System for Optogenetics?" led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).
The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Covidien, a manufacturer of medical devices, pharmaceuticals and medical supplies, based in Mansfield, Mass., has pledged $375,000 and is a "Visionary" level supporter.
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
Selenium may offer an intervention strategy for the treatment of prostate cancer according to results of a study from the laboratory of Allen Gao, PhD, which will be presented by Yan Hu, PhD, Departments of Medicine and Pharmacology and Therapeutics, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.
Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients - This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.
› Verified 1 days ago
Dr. James C Gedney, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 50 Memorial Blvd, Aquidneck Medical Associates, Inc, Newport, RI 02840 Phone: 401-847-2290 Fax: 401-849-8446 | |
Jennifer Keryn Enos, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20 Powel Avenue, Newport, RI 02840 Phone: 401-848-5556 | |
Dr. Gail E Carreau, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 19 Friendship St, Suite 220, Newport, RI 02840 Phone: 401-848-5556 Fax: 401-519-2994 | |
Martha Higginbotham Aldridge, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Friendship Street, Suite 200, Newport, RI 02840 Phone: 401-848-5556 Fax: 401-845-4379 | |
Dr. Virginia H Bass, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19 Friendship St Unit 220, Newport, RI 02840 Phone: 401-848-5556 Fax: 401-845-4379 | |
Martha Christine Moe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20 Powel Avenue, Newport, RI 02840 Phone: 401-848-5556 |